Bristol Myers Squibb to Build $2.3B Houston Drug Campus at Generation Park
Bristol Myers Squibb will invest $2.3 billion to build a roughly 600,000-square-foot drug manufacturing campus in Houston’s Generation Park. The multi-modality facility will make small molecules, biologics and antibody-drug conjugates with a footprint designed to adapt as the pipeline changes. The project is expected to hire nearly 500 people and supports the firm’s broader $40 billion U.S. investment plan.